谷歌浏览器插件
订阅小程序
在清言上使用

Donor-derived CD19 CAR-T Cells Versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation.

CURRENT MEDICAL SCIENCE(2023)

引用 1|浏览23
暂无评分
关键词
CD19-positive B-cell acute lymphoblastic leukemia,relapse,donor-derived CD19 chimeric antigen receptor T cells,chemo-donor lymphocyte infusion
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要